Summary
- Cigna reported strong fourth quarter earnings that markets quickly ignored.
- Selling pressure pushed the stock lower after the Express Scripts deal.
- Stock trades at a discount to UnitedHealth Group.
- This idea was discussed in more depth with members of my private investing community, DIY Value Investing. Start your free trial today »
After UnitedHealth Group (UNH) continued its bounce back from March lows in just the last week, Cigna Corporation (CI) may do the same. The stock lost nearly one-quarter of its value from 52-week highs following the closing of its tie-up with Express Scripts. In its fourth quarter report, the company’s outlook clouded its strong numbers. With the stock now in deep value territory, should investors consider investing in CI stock?
